RxDoctor Payments DataLook up a doctor →

Erlinda Gordon

Pediatric Hematology-Oncology · Monterey, CANPI 1922191717

Payments from drug & device makers

$1,306,290in general payments, 2019–2025

Across 486 payments — averaging $2687.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aadi Bioscience, Inc.$828K
  • Jazz Pharmaceuticals Inc.$405K
  • E.r. Squibb & Sons, L.L.C.$62K
  • Merck$831
  • Daiichi Sankyo Inc.$794
  • Bayer$649
  • plus $8K from 54 others
$940in research payments, 2019–2025

Across 1 payment — averaging $940.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$940

What the payments were for

  • Consulting fees$8,48839%
  • Speaking & faculty fees$1,5007%
  • Food & beverage$11,40653%
  • Education$1000%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Aadi Bioscience, Inc.32$828,309
Jazz Pharmaceuticals Inc.6$405,312
E.r. Squibb & Sons, L.L.C.11$62,400
Merck33$831
Daiichi Sankyo Inc.32$794
Bayer32$649
Incyte Corporation25$616
Novartis26$556
Coherus Oncology, Inc.37$544
AstraZeneca(2 entities)17$514
Ipsen Biopharmaceuticals, Inc15$441
Lilly USA, LLC17$410
Seagen Inc.18$407
Taiho Oncology, Inc.15$318
Pfizer9$244
Karyopharm Therapeutics Inc.8$241
Takeda Pharmaceuticals U.S.A., Inc.9$240
Amgen9$213
Gilead(2 entities)8$201
Eisai Inc.8$172
Dendreon Pharmaceuticals LLC6$159
Sanofi6$154
Kyowa Kirin, Inc.6$142
Genmab U.S., Inc.5$140
Blueprint Medicines Corporation6$139
GSK5$120
Agios Pharmaceuticals, Inc.5$119
Tersera Therapeutics LLC4$116
Johnson & Johnson4$99
Springworks Therapeutics, Inc.4$96
Genentech USA, Inc.3$91
Tolmar Pharmaceuticals, Inc.4$89
Puma Biotechnology, Inc.2$87
Bristol Myers Squibb4$84
Deciphera Pharmaceuticals Inc.4$83
Spectrum Pharmaceuticals Inc.3$78
Tesaro, Inc.2$72
Sobi, Inc3$63
Caris MPI, Inc.1$60
Morphosys, US Inc.3$59
Heron Therapeutics, Inc.3$58
Array Biopharma Inc2$55
Mylan Institutional Inc.3$55
GE HealthCare2$50
AbbVie2$37
Helsinn Therapeutics (U.S.), Inc.2$36
Acrotech Biopharma Inc.1$35
Beigene USA, Inc.1$34
Janssen Scientific Affairs, LLC1$32
Boehringer Ingelheim1$30
EMD Serono, Inc.1$28
Blue Earth Diagnostics1$27
Progenics Pharmaceuticals, Inc.1$27
Stemline Therapeutics Inc.1$25
Iovance Biotherapeutics, Inc.2$25
Global Blood Therapeutics, Inc.1$24
Tolmar, Inc.1$24
CTI Biopharma Corp.1$24
Teva Pharmaceuticals USA, Inc.1$23
Catalyst Pharmaceuticals, Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,306,290 in reported general payments places this provider in the 90th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California →

Other pediatric hematology-oncology in Monterey

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →